Arcutis Biotherapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Arcutis Biotherapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q3 2024.
  • Arcutis Biotherapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.06M, a 16.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.06M -$395K -16.1% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $2.16M -$383K -15% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $2.26M -$370K -14% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.36M -$360K -13.2% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $2.46M -$348K -12.4% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $2.55M -$336K -11.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $2.63M -$327K -11% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $2.72M -$319K -10.5% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $2.8M -$312K -10% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $2.88M -$309K -9.68% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $2.96M -$308K -9.42% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $3.04M -$309K -9.23% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $3.12M -$377K -10.8% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $3.19M -$438K -12.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $3.27M +$3.04M +1346% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $3.35M +$3.09M +1169% Dec 31, 2020 10-K 2022-02-22
Q3 2020 $3.49M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $3.63M Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $226K Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $264K Dec 31, 2019 10-K 2021-02-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.